Key result
Surgical site infection remains a major global problem, affecting up to 50% of patients within 30 days post-operation depending on risk factors, prompting various recent global research initiatives.
Surgical site infection remains a major global research priority, affecting up to 50% of patients depending on risk factors.
Surgical site infection (SSI) is a global problem, and has been highlighted as the foremost research priority for perioperative researchers across high-, middle- and low-income settings. Depending on the degree of intraoperative contamination, baseline patient risk and other infection control measures, as many as 50% of patients can suffer surgical wound infections within the 30-days after an operation. As a result, SSI has been the focus of several recent global initiatives including randomised controlled trials of health technologies, quality improvement bundle studies, and prospective cohort studies.
No takes yet. Share an insight, caveat, or question.
James Glasbey (2020) conducted a review in Surgical site infection (SSI). Antibiotic prophylaxis was evaluated. Surgical site infection remains a major global problem, affecting up to 50% of patients within 30 days post-operation depending on risk factors, prompting various recent global research initiatives.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: